pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$BSXBOSTON SCIENTIFIC CORP

$BSX42.60-1.46%
Marlborough, MA, USupdated 1d ago

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 8
  • tagAdCom185 co-mentions · 185 sources
  • tagPMA Approval156 co-mentions · 156 sources
  • tagRecall86 co-mentions · 66 sources
  • tag510(k) Clearance29 co-mentions · 29 sources
  • company$SLFPFSTANDARD LIFE PLC27 co-mentions · 27 sources
  • company$SLFPYSTANDARD LIFE PLC27 co-mentions · 27 sources
  • tagCardiology15 co-mentions · 13 sources
  • tagUrology12 co-mentions · 10 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
104
approvals ytd
0
recalls ytd
1

Pipeline(0)

no pipeline products on record

📅 Upcoming

Oct 21, 2026
earnings
$BSX42.60-1.46%
in 16d
BOSTON SCIENTIFIC CORP earnings
BOSTON SCIENTIFIC CORP
→
Oct 28, 2026
earnings
$BSX42.60-1.46%
in 23d
BOSTON SCIENTIFIC CORP earnings
BOSTON SCIENTIFIC CORP
→

🕒 Recent(90d)

earnings (2)
Jul 29, 2026
earnings
$BSX42.60-1.46%
2mo ago
BOSTON SCIENTIFIC CORP earnings
BOSTON SCIENTIFIC CORP
→
Jul 22, 2026
earnings
$BSX42.60-1.46%
3mo ago
BOSTON SCIENTIFIC CORP earnings
BOSTON SCIENTIFIC CORP
→
view all catalysts →

Active trials

  • N/AEffectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacingactive not recruitingn=297
  • N/AA Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillationnot yet recruitingn=650
  • N/ADose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Deviceactive not recruitingn=36
  • N/ANeural Cardiac Therapy for Heart Failure Study (NECTAR-HF)active not recruitingn=118
  • N/AEvaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillationrecruitingn=571
  • N/AImpact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)not yet recruitingn=50
  • —cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asiaactive not recruitingn=433
  • N/ARepeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation Systemactive not recruitingn=376
🐶 Hiring Signal
next earnings Oct 21, 2026
No open roles indexed yet — view BOSTON SCIENTIFIC CORP jobs →

News

  • Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters
    Boston Scientific Imager II Angiographic Catheters removed due to a manufacturing issue leading to tip detachment; could result in procedural delays, embolism
    fda_medwatch · 9d ago
  • Lonza to build new US factory; Samsung Bio signs $262M contract
    Plus, news about Boston Scientific. Lonza’s new factory in the US: Lonza is expanding its US capacity with a new commercial spray-drying facility in Bend, OR. The new build is ...
    endpoints · 24d ago
  • Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuries
    Boston Scientific has issued another recall, this time for its spinal cord implant used to treat pain.
    fiercebiotech · 26d ago
  • Boston Scientific cyberattack likely to have ‘material impact’ on financial results
    The recent cyberattack on Boston Scientific is looking more serious than the medtech major first thought, with the company predicting a possible hit to its third-quarter and full-year results.
    fiercebiotech · 27d ago
  • Spinal Cord Stimulator Recall: Boston Scientific Removes Infinion CX Lead
    Infinion CX Lead bodies may experience mechanical stress at the anchor site resulting in inadequate stimulation requiring lead explant and replacement.
    fda_medwatch · 1mo ago
  • Novocure hit by cyberattack exposing patient data
    Novocure has become the latest medtech company to be hit by a cyberattack, with the oncology specialist revealing that unauthorized access to some of its information systems exposed patient and emp…
    fiercebiotech · 1mo ago
  • Boston Scientific halts sales of angiographic catheters amid 2 serious injuries
    Boston Scientific has told its customers to stop using its Imager II angiographic catheters upon learning that a manufacturing issue has impacted the tips of the devices.
    fiercebiotech · 1mo ago
  • Early Alert: Angiographic Catheter Issue from Boston Scientific
    Boston Scientific Imager II Angiographic Catheters removed due to a manufacturing issue leading to tip detachment; could result in procedural delays, embolism
    fda_medwatch · 1mo ago
  • Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
    This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.
    fiercebiotech · 1mo ago
  • Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection System
    ENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use.
    fda_medwatch · 1mo ago
view all news mentions →
identifiers
ticker
$BSX
SEC CIK
0000885725
country
US
source
sec_tickers
mentioned in
10news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 42m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?